問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Linkou Chang Gung Medical Foundation
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2011-08-01 - 2014-07-31
Condition/Disease
Test Drug
Participate Sites1Sites
Terminated1Sites
2009-12-14 - 2011-12-14
2010-05-26 - 2012-12-31
Participate Sites5Sites
Terminated5Sites
2017-11-01 - 2021-12-08
Acute primary cerebral hemorrhage
Three-dose combination(telmisartan, amlodipine, indapamide)
Participate Sites4Sites
Recruiting3Sites
Study ended1Sites
Division of Neurology
2015-01-01 - 2018-12-31
2014-04-01 - 2017-09-30
Participate Sites2Sites
Terminated2Sites
2014-10-01 - 2016-10-30
2015-01-01 - 2016-07-31
2007-05-01 - 2009-04-30
Participate Sites9Sites
Terminated9Sites
全部
